Atom | Accelerating Product Excellence in Innovation and for Clinical Adoption (U24 Clinical Trial Not Allowed)

Funder: National Institutes of Health (NIH)

Due Dates: January 25, 2026 (anticipated)

Funding Amounts: Not yet specified; cooperative agreement (U24) mechanism; details forthcoming in NOFO.

Summary: Supports Resource Centers to accelerate product development and clinical adoption in tissue engineering and regenerative medicine, advancing products toward first-in-human studies.

Key Information: This is a forecasted opportunity; final details and application instructions will be released in the upcoming NOFO.

Accelerating Product Excellence in Innovation and for Clinical Adoption (U24 Clinical Trial Not Allowed)

Sign in to see full grant listing